Enzymatica AB's Upcoming Digital Press Briefing
Enzymatica AB welcomes everyone to an exciting upcoming digital press briefing. This event aligns with their commitment to sharing knowledge and advancements in respiratory health, particularly focusing on the effectiveness of ColdZyme. Researchers will present data from two substantial independent studies that delve into the impact of this unique product.
Event Details You Can't Miss
The digital press briefing is scheduled for an intriguing session filled with valuable insights. Attendees can expect engaging presentations that will foster a productive Q&A environment. The agenda for the event includes:
Research Presentation
The two independent research studies concerning ColdZyme will be introduced by the researchers. They will present their findings during the first part of the briefing:
- 13:00–14:10: Findings Presentation and Q&A with Researchers
Company Overview and Leadership Discussion
Following the research presentation, attendees will have the chance to hear from Enzymatica's leadership, including CEO Claus Egstrand and Chairman Bengt Baron. They will share a comprehensive overview of the company's initiatives and future endeavors:
- 14:15–15:00: Overview Presentation and Q&A with CEO and Chairman
How to Participate in the Live Broadcast
To ensure participation in this informative event, registration is required. The live broadcast will provide an opportunity for interaction with the presenters and allows for participants to ask questions directly. This engaging format is an invitation to a dialogue about the impactful findings of the research studies.
Stay Updated with the Latest from Enzymatica
In addition to the event itself, further updates and information on the studies will be accessible via their media channels. Participants are encouraged to keep an eye on announcements that highlight the significance of the studies published in peer-reviewed journals and platforms showcasing the efficacy of ColdZyme.
For those seeking additional information or who would like to review the earlier press release from Enzymatica, the results from February 28 are readily available online. This release contains further insights into how ColdZyme addresses underlying respiratory issues, reducing symptoms and sick days significantly!
Contact Information for Inquiries
For any additional inquiries or detailed questions surrounding the content of the press briefing, interested parties can reach out to Enzymatica's Corporate Communications. Although email details cannot be specified here, their dedicated team is ready to assist.
Frequently Asked Questions
When is the press briefing scheduled?
The digital press briefing is set for March 5, 2025.
Who will be presenting at the briefing?
Researchers of the independent studies and Enzymatica's CEO and Chairman will lead the presentations.
How can I register for the live event?
Registration to participate in the live broadcast can be done through the Enzymatica website.
What topics will be discussed?
The briefing will cover findings from ColdZyme research studies and present an overview of Enzymatica's current and future initiatives.
Where can I find further information?
For more information, please contact Enzymatica’s Corporate Communications.
